Human epidermal growth factor receptor 2 (HER-2) is a member of epidermal growth factor receptor (EGFR) family, which is overexpressed in breast cancer, ovary cancer, uterine endometrioid carcinoma, gastric carcinomas, glioblastomas, etc (Jackson et al., 2013). Here, EGFR is linked to ovarian cancer.